Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma

Human T cell leukemia virus type 1 (HTLV-1) is the etiological agent of adult T cell leukemia/lymphoma (ATL), HTLV-1 associated myelopathy (HAM/TSP), and of a number of inflammatory diseases with an estimated 10–20 million infected individuals worldwide. Despite a number of therapeutic approaches, a...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Francesca Marino-Merlo, Antonio Mastino, Sandro Grelli, Olivier Hermine, Ali Bazarbachi, Beatrice Macchi
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2018-05-01
Серии:Frontiers in Microbiology
Предметы:
HTLV-1
ATL
antiviral agents
biological therapy
targeted therapy
Online-ссылка:http://journal.frontiersin.org/article/10.3389/fmicb.2018.00925/full
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы